{"transactions":[{"id":2359624,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":129717,"kind":"person","name":"Faulkingham Dell","position":1,"cik":"0001776024","reported_name":"Faulkingham Dell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CCO"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2022-03-03T02:10:56.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date."}],"balance_after":200000,"derivative":{"exercise_price":2.16,"expiration_date":"2032-02-28","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001562180-22-002162","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218022002162/primarydocument.xml","form_type":"4"}},{"id":2359623,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":129717,"kind":"person","name":"Faulkingham Dell","position":1,"cik":"0001776024","reported_name":"Faulkingham Dell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CCO"}}],"security":"Common Stock","published_at":"2022-03-03T02:10:56.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":957,"price":2.1707,"value":2077.3599,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021."}],"balance_after":173841,"source":{"system":"sec-edgar","filing":"0001562180-22-002162","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218022002162/primarydocument.xml","form_type":"4"}},{"id":2359622,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":129717,"kind":"person","name":"Faulkingham Dell","position":1,"cik":"0001776024","reported_name":"Faulkingham Dell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CCO"}}],"security":"Common Stock","published_at":"2022-03-03T02:10:56.000Z","date":"2022-03-01","kind":"sale","acquired":false,"shares":5748,"price":2.1707,"value":12477.1836,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020."}],"balance_after":174798,"source":{"system":"sec-edgar","filing":"0001562180-22-002162","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218022002162/primarydocument.xml","form_type":"4"}},{"id":2359621,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":129717,"kind":"person","name":"Faulkingham Dell","position":1,"cik":"0001776024","reported_name":"Faulkingham Dell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CCO"}}],"security":"Common Stock","published_at":"2022-03-03T02:10:56.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One-third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date."}],"balance_after":180546,"source":{"system":"sec-edgar","filing":"0001562180-22-002162","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218022002162/primarydocument.xml","form_type":"4"}},{"id":2359620,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":129717,"kind":"person","name":"Faulkingham Dell","position":1,"cik":"0001776024","reported_name":"Faulkingham Dell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CCO"}}],"security":"Common Stock","published_at":"2022-03-03T02:10:56.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":6479,"price":2.1548,"value":13960.9492,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021."}],"balance_after":130546,"source":{"system":"sec-edgar","filing":"0001562180-22-002162","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218022002162/primarydocument.xml","form_type":"4"}},{"id":2763446,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":129717,"kind":"person","name":"Faulkingham Dell","position":1,"cik":"0001776024","reported_name":"Faulkingham Dell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CCO"}}],"security":"Common Stock","published_at":"2021-04-02T00:35:09.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":952,"price":3.4,"value":3236.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021."}],"balance_after":137025,"source":{"system":"sec-edgar","filing":"0001562180-21-002544","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218021002544/primarydocument.xml","form_type":"4"}},{"id":2778764,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":129717,"kind":"person","name":"Faulkingham Dell","position":1,"cik":"0001776024","reported_name":"Faulkingham Dell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Common Stock","published_at":"2021-03-18T23:18:51.000Z","date":"2021-03-16","kind":"grant","acquired":true,"shares":9152,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"As previously disclosed, in February 2020, the Reporting Person was granted performance-based restricted stock unit awards (\"PSUs\") pursuant to the Issuer's 2014 Incentive Plan, as amended. The PSUs vest in connection with the achievement of specified commercial and regulatory milestones. On February 25, 2021, the Company reported its financial results for the year ended December 31, 2020.  Subsequently, in accordance with the terms of the grant, the Issuer's Compensation Committee certified the achievement of a commercial milestone and, as a result, one third of the reported PSUs will vest on each of March 31, 2021, February 28, 2022 and February 28, 2023, subject to the Reporting Person's continued service with the Issuer on each vesting date."}],"balance_after":137977,"source":{"system":"sec-edgar","filing":"0001562180-21-002357","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218021002357/primarydocument.xml","form_type":"4"}},{"id":2818975,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":129717,"kind":"person","name":"Faulkingham Dell","position":1,"cik":"0001776024","reported_name":"Faulkingham Dell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2021-03-02T21:08:51.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date."}],"balance_after":110000,"derivative":{"exercise_price":3.46,"expiration_date":"2031-02-26","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001562180-21-001786","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218021001786/primarydocument.xml","form_type":"4"}},{"id":2818974,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":129717,"kind":"person","name":"Faulkingham Dell","position":1,"cik":"0001776024","reported_name":"Faulkingham Dell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Common Stock","published_at":"2021-03-02T21:08:51.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":6749,"price":3.3961,"value":22920.2789,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2020."}],"balance_after":128825,"source":{"system":"sec-edgar","filing":"0001562180-21-001786","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218021001786/primarydocument.xml","form_type":"4"}},{"id":2818973,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":129717,"kind":"person","name":"Faulkingham Dell","position":1,"cik":"0001776024","reported_name":"Faulkingham Dell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Common Stock","published_at":"2021-03-02T21:08:51.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date."}],"balance_after":135574,"source":{"system":"sec-edgar","filing":"0001562180-21-001786","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218021001786/primarydocument.xml","form_type":"4"}},{"id":3126524,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":129717,"kind":"person","name":"Faulkingham Dell","position":1,"cik":"0001776024","reported_name":"Faulkingham Dell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Common Stock","published_at":"2020-06-02T20:34:22.000Z","date":"2020-06-01","kind":"sale","acquired":false,"shares":6426,"price":11.58,"value":74413.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover tax withholding obligations in connection with the vesting and settlement of 100% of the reporting person's restricted stock units granted on May 31, 2019."}],"balance_after":73574,"source":{"system":"sec-edgar","filing":"0001562180-20-004068","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218020004068/primarydocument.xml","form_type":"4"}},{"id":3237399,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":129717,"kind":"person","name":"Faulkingham Dell","position":1,"cik":"0001776024","reported_name":"Faulkingham Dell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Stock Option (Right to buy)","published_at":"2020-03-03T00:25:02.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":94000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter."}],"balance_after":94000,"derivative":{"exercise_price":8.87,"expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":94000},"source":{"system":"sec-edgar","filing":"0001562180-20-001929","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218020001929/primarydocument.xml","form_type":"4"}},{"id":3237398,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":129717,"kind":"person","name":"Faulkingham Dell","position":1,"cik":"0001776024","reported_name":"Faulkingham Dell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Common Stock","published_at":"2020-03-03T00:25:02.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date."}],"balance_after":80000,"source":{"system":"sec-edgar","filing":"0001562180-20-001929","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218020001929/primarydocument.xml","form_type":"4"}},{"id":3504291,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":129717,"kind":"person","name":"Faulkingham Dell","position":1,"cik":"0001776024","reported_name":"Faulkingham Dell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2019-06-03T20:31:48.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted by the Issuer as an inducement material to the reporting person's entering into employment with Akebia in accordance with Nasdaq Listing Rule 5635(c)(4).  The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter."}],"balance_after":250000,"derivative":{"exercise_price":4.45,"expiration_date":"2029-05-31","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001562180-19-003224","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218019003224/primarydocument.xml","form_type":"4"}},{"id":3504290,"issuer":{"id":6105,"kind":"organization","name":"Akebia Therapeutics, Inc."},"owners":[{"id":129717,"kind":"person","name":"Faulkingham Dell","position":1,"cik":"0001776024","reported_name":"Faulkingham Dell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CCO"}}],"security":"Common Stock","published_at":"2019-06-03T20:31:48.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan, as amended.  100% of the restricted stock units will vest on the first anniversary of the grant date."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001562180-19-003224","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1517022/000156218019003224/primarydocument.xml","form_type":"4"}}]}